BRAF and neoplasm: Tumour pigmentation status revealed that levels of 15 metabolites were altered, whereas other features, such as BRAF mutation status, initial site of metastasis and patient sex, did not contribute to metabolic variance in these models (Fig. 2a and Supplementary Table 5).